跳转到主要内容
  • 关于 ELGA
    • 关于 ELGA
    • 超纯水
    • 纯化技术
    • 水中杂质
    • 白皮书
    • 认证合作伙伴
    • 可持续发展
    • 降低临床风险
    • 招贤纳士
    • 活动
    • HPLC 的制药应用
    • HPLC 水纯度
  • 博客
    • Analytical Chemistry
    • Clinical & Pharma
    • Cool Science
    • Environment and sustainability
    • Life in the lab
    • Purelab product design
    • Science of the future
    • Water Purity
    • Water in the lab
  • 联系信息
  • English
  • Deutsch
  • Español
  • Français
  • Italiano
  • Português
  • 日本語
首页 ELGA LabWater
  • 产品
  • 应用
  • 案例分析
  • 支持
  • 产品
    • PURELAB
    • CENTRA
    • MEDICA
    • BIOPURE
    • ELGA 全产品系列
  • 应用
  • 案例分析
    • 雅培诊断的南亚团队选用 ELGA MEDICA 系统
    • 1+ 级超纯水对非专利药物开发的重要性
    • Beam Me Up, Scotty: PURELAB® Option Q Delivers Essential Ultra Pure Water
    • Clean Water for a Clean Future
    • Critital Tests Benefit from PURELAB® Option Reliable Pure Water
    • DASA:巴西最大的医疗诊断公司
    • ELGA 帮助免疫血清学实验室最大程度地增加运行时间
    • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
    • PURELAB® Option R Guarantees Pure Water for Leading Microfluidics Technology
    • PURELAB® Pulse Delivers Reliable Water Quality and Quantity for a Wide Range of Applications
    • PURELAB® flex:适合当今研究方法的理想培训系统
    • Powering Cutting-Edge Gene Research
    • Sichere Reinstwasserversorgung für präzise Produkttests
    • Zentrale Reinstwasser-Aufbereitung für Analyser
    • 城市综合医院为西门子 ADVIA® 分析仪选配 MEDICA® Pro
    • ELGA LabWater and Beckman Coulter Join Forces
    • Applied New Technologies Department Improves ICP, IC & HPLC Sample Turnaround Times with PURELAB®
    • 借助超纯水,解开南极的秘密
    • Advancing Genetic Technologies
    • Cross Infection Control: Pure and Simple
    • Researching effective new ways to prevent cardiovascular disease at the University of Columbia
  • 支持
    • 支持和服务
    • 实验室规划
    • 注册产品
    • Register Your Product (USA & Canada Only)
  • 产品
    • PURELAB
      • PURELAB® flex 1 & 2
      • PURELAB® flex 3 & 4
    • CENTRA
      • CENTRA® 60/120
      • CENTRA® RDS
      • CENTRA® R200
    • MEDICA
      • MEDICA® 7/15
      • MEDICA® EDI 15/30
      • MEDICA® Pro EDI 60/120
      • MEDICA® Pro-LPS
      • MEDICA® Pro-R 和 Pro-RE
      • MEDICA® R200
    • BIOPURE
      • BIOPURE 7/15
      • BIOPURE 60/120
      • BIOPURE 200/300/600
    • ELGA 全产品系列
      • PURELAB® Classic
  • 应用
  • 案例分析
    • 雅培诊断的南亚团队选用 ELGA MEDICA 系统
    • 1+ 级超纯水对非专利药物开发的重要性
    • Beam Me Up, Scotty: PURELAB® Option Q Delivers Essential Ultra Pure Water
    • Clean Water for a Clean Future
    • Critital Tests Benefit from PURELAB® Option Reliable Pure Water
    • DASA:巴西最大的医疗诊断公司
    • ELGA 帮助免疫血清学实验室最大程度地增加运行时间
    • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
    • PURELAB® Option R Guarantees Pure Water for Leading Microfluidics Technology
    • PURELAB® Pulse Delivers Reliable Water Quality and Quantity for a Wide Range of Applications
    • PURELAB® flex:适合当今研究方法的理想培训系统
    • Powering Cutting-Edge Gene Research
    • Sichere Reinstwasserversorgung für präzise Produkttests
    • Zentrale Reinstwasser-Aufbereitung für Analyser
    • 城市综合医院为西门子 ADVIA® 分析仪选配 MEDICA® Pro
    • ELGA LabWater and Beckman Coulter Join Forces
    • Applied New Technologies Department Improves ICP, IC & HPLC Sample Turnaround Times with PURELAB®
    • 借助超纯水,解开南极的秘密
    • Advancing Genetic Technologies
    • Cross Infection Control: Pure and Simple
    • Researching effective new ways to prevent cardiovascular disease at the University of Columbia
  • 支持
    • 支持和服务
    • 实验室规划
    • 注册产品
    • Register Your Product (USA & Canada Only)
  • English
  • Deutsch
  • Español
  • Français
  • Italiano
  • Português
  • 日本語
  • 隐私政策
  • 条款和条件
  • 全球法律合规
  • 专利
  • 页面操作员
  • 首页
  • Node
  • Gold Nanoparticles can Penetrate Deep Inside Brain Cells
Clinical & Pharma

Gold Nanoparticles can Penetrate Deep Inside Brain Cells

3 8月 2020
- by Dr Alison Halliday

Carbon nanoparticles with gold mesh

A new study demonstrates the potential of using ultrasmall gold nanoparticles for imaging or delivering drugs into the brain.

As its name suggests, the blood-brain–barrier provides a defence against any infectious agents and toxins that are in our blood. But one of the major challenges in finding cures for brain diseases – such as tumours, stroke and dementia – is that there is no truly efficient way to get treatments to cross it.

Nanoparticle delivery systems offer promising new opportunities for transporting drug molecules across the blood-brain–barrier. Due to their small size (<2nm), ultrasmall gold nanoparticles may be particularly well suited for transporting substances into cells.

In recent years advanced three–dimensional cell culture systems, such as multicellular spheroids, are emerging as powerful tools to test the penetration ability of potential therapeutics. In 3D brain spheroids, the blood-brain–barrier is simulated by the outer layer, which prevents the movement of drugs or particles from the growth media (the ‘blood’) into the core (the ‘brain’).

Tracking Nanoparticles 

In a new study, published in Acta Biomaterialia, a team of researchers investigated the ability of ultrasmall gold nanoparticles to penetrate brain cells in a 3D brain spheroid model.1 The researchers prepared three different kinds of ultrasmall gold nanoparticles, each tagged with a different fluorescent dye to enable them to track their uptake into cells or spheroids using confocal scanning microscopy.

The team used ultrapure water generated from an ELGA PURELAB® laboratory water purification system for all synthesis and purification steps, minimising the risk of introducing contaminants that may affect their results. They first carried out 2D cell culture experiments to test the ability of their nanoparticles to penetrate three different types of cells that make up the brain (astrocytes, pericytes and endothelial cells) grown in the same dish. They found that all three kinds of nanoparticles readily entered all cell types. Two were even able to get inside the nucleus, the central part of the cell containing its DNA.

Entering the Third Dimension

The team went on to create a 3D brain spheroid model from the same three cell types. They showed that after 120 hours, these self–assemble into spheroids with the core made up mainly of astrocytes, covered with pericytes, while endothelial cells form the outer surface. 

They showed that all three types of nanoparticle were able to enter the spheroids, but dissolved unattached dye molecules did not. However, when they then added a substance that opened the outer layer of the spheroid, the unattached dyes were then able to get inside – proving the presence of a functional blood-brain–barrier.

A Promising New Drug Delivery System

In this study, the researchers successfully synthesised three kinds of fluorescent ultrasmall gold nanoparticles and proved they can penetrate brain cells grown in 2D and 3D culture.

Ultrasmall gold nanoparticles offer the potential to become an effective system for delivering small biomolecules and dyes across the blood-brain–barrier – offering the hope of more effective treatments for people with brain disease in the future.

Why Choose ELGA LabWater?

ELGA has been a trusted name in pure and ultrapure water since 1937. Our dedication to ultrapure and pure water is a guarantee that we will continue to provide the best solutions with the best service.
 

Reference:

1. Sokolova, V. et al. Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid model. Acta Biomaterialia 2020;11:349–362 https://doi.org/10.1016/j.actbio.2020.04.023
 

Dr Alison Halliday

After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

 

risk whitepaper

When lives are at stake, there is no margin for error. Your clinical analyser must receive a constant and reliable supply of CLRW. 

Find out how to protect your test results

                   Click Here

 

  • Enquiry
  • 获取报价
  • 预订演示
  • 联系获认证的合作伙伴

Enquiry

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

获取报价

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

预订演示

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

Elga LabWater 总部

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
United Kingdom
电话: +44 (0) 203 567 7300
传真:+44 (0) 203 567 7205

超纯水专家

  • 支持和服务
  • 活动

案例研究

  • 雅培诊断
  • DASA 医学诊断
  • NeoDIN 医学研究所
  • 北斯塔福德郡 NHS 信托大学医院
  • Olsberg 职业技术学院

资源

  • 了解超纯水
  • 白皮书
  • 水纯化技术
  • 实验室应用
  • 水中杂质

Blogs

  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?
  • 语言
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Veolia 其他站点
    • Veolia
    • Veolia Fondation
    • Veolia Water Technologies

© VWS (UK) Ltd. 以 ELGA®LabWater 的名义经营业务。2021- 保留所有权利
ELGA 是 Veolia 旗下全球实验室用水品牌。

  • 隐私政策
  • 条款和条件
  • 全球法律合规
  • 专利
  • 页面操作员
Elga Veolia
TOP

© 2017 ELGA Veolia